 | • レポートコード：QYR9ST03901 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、ギランバレー症候群の世界市場について調査・分析し、ギランバレー症候群の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（静脈内免疫グロブリン、血漿交換、鎮痛薬、抗痙攣薬、LMWH）、用途別（病院薬局、小売薬局、ホームケア、クリニック）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のギランバレー症候群市場動向 ・主要企業別マーケットシェア ・ギランバレー症候群の種類別市場規模2014-2019 （静脈内免疫グロブリン、血漿交換、鎮痛薬、抗痙攣薬、LMWH） ・ギランバレー症候群の用途別市場規模2014-2019 （病院薬局、小売薬局、ホームケア、クリニック） ・ギランバレー症候群の北米市場：主要企業・種類別/用途別市場規模 ・ギランバレー症候群のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・ギランバレー症候群の中国市場：主要企業・種類別/用途別市場規模 ・ギランバレー症候群の日本国内市場：主要企業・種類別/用途別市場規模 ・ギランバレー症候群の東南アジア市場：主要企業・種類別/用途別市場規模 ・ギランバレー症候群のインド市場：主要企業・種類別/用途別市場規模 ・ギランバレー症候群の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Grifols、CSL Behring、Octapharma、Nihon Pharmaceutical、Akari Therapeutics、China Biologic Products Holdings、Biotest、Kedrion） ・ギランバレー症候群の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Guillain-Barré Syndrome is a rapid-onset muscle weakness caused by the immune system damaging the peripheral nervous system.In 2018, the global Guillain-Barré Syndrome market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Guillain-Barré Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Guillain-Barré Syndrome development in United States, Europe and China.
The key players covered in this study
Grifols
CSL Behring
Octapharma
Nihon Pharmaceutical
Akari Therapeutics
China Biologic Products Holdings
Biotest
Kedrion
Market segment by Type, the product can be split into
Intravenous Immunoglobulin
Plasma Exchange
Analgesics
Anticonvulsants
LMWH
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Home Care
Clinics
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Guillain-Barré Syndrome status, future forecast, growth opportunity, key market and key players.
To present the Guillain-Barré Syndrome development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Guillain-Barré Syndrome are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Guillain-Barré Syndrome Market Size Growth Rate by Type (2014-2025)
1.4.2 Intravenous Immunoglobulin
1.4.3 Plasma Exchange
1.4.4 Analgesics
1.4.5 Anticonvulsants
1.4.6 LMWH
1.5 Market by Application
1.5.1 Global Guillain-Barré Syndrome Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Home Care
1.5.5 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Guillain-Barré Syndrome Market Size
2.2 Guillain-Barré Syndrome Growth Trends by Regions
2.2.1 Guillain-Barré Syndrome Market Size by Regions (2014-2025)
2.2.2 Guillain-Barré Syndrome Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Guillain-Barré Syndrome Market Size by Manufacturers
3.1.1 Global Guillain-Barré Syndrome Revenue by Manufacturers (2014-2019)
3.1.2 Global Guillain-Barré Syndrome Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Guillain-Barré Syndrome Market Concentration Ratio (CR5 and HHI)
3.2 Guillain-Barré Syndrome Key Players Head office and Area Served
3.3 Key Players Guillain-Barré Syndrome Product/Solution/Service
3.4 Date of Enter into Guillain-Barré Syndrome Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Guillain-Barré Syndrome Market Size by Type (2014-2019)
4.2 Global Guillain-Barré Syndrome Market Size by Application (2014-2019)
5 United States
5.1 United States Guillain-Barré Syndrome Market Size (2014-2019)
5.2 Guillain-Barré Syndrome Key Players in United States
5.3 United States Guillain-Barré Syndrome Market Size by Type
5.4 United States Guillain-Barré Syndrome Market Size by Application
6 Europe
6.1 Europe Guillain-Barré Syndrome Market Size (2014-2019)
6.2 Guillain-Barré Syndrome Key Players in Europe
6.3 Europe Guillain-Barré Syndrome Market Size by Type
6.4 Europe Guillain-Barré Syndrome Market Size by Application
7 China
7.1 China Guillain-Barré Syndrome Market Size (2014-2019)
7.2 Guillain-Barré Syndrome Key Players in China
7.3 China Guillain-Barré Syndrome Market Size by Type
7.4 China Guillain-Barré Syndrome Market Size by Application
8 Japan
8.1 Japan Guillain-Barré Syndrome Market Size (2014-2019)
8.2 Guillain-Barré Syndrome Key Players in Japan
8.3 Japan Guillain-Barré Syndrome Market Size by Type
8.4 Japan Guillain-Barré Syndrome Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Guillain-Barré Syndrome Market Size (2014-2019)
9.2 Guillain-Barré Syndrome Key Players in Southeast Asia
9.3 Southeast Asia Guillain-Barré Syndrome Market Size by Type
9.4 Southeast Asia Guillain-Barré Syndrome Market Size by Application
10 India
10.1 India Guillain-Barré Syndrome Market Size (2014-2019)
10.2 Guillain-Barré Syndrome Key Players in India
10.3 India Guillain-Barré Syndrome Market Size by Type
10.4 India Guillain-Barré Syndrome Market Size by Application
11 Central & South America
11.1 Central & South America Guillain-Barré Syndrome Market Size (2014-2019)
11.2 Guillain-Barré Syndrome Key Players in Central & South America
11.3 Central & South America Guillain-Barré Syndrome Market Size by Type
11.4 Central & South America Guillain-Barré Syndrome Market Size by Application
12 International Players Profiles
12.1 Grifols
12.1.1 Grifols Company Details
12.1.2 Company Description and Business Overview
12.1.3 Guillain-Barré Syndrome Introduction
12.1.4 Grifols Revenue in Guillain-Barré Syndrome Business (2014-2019)
12.1.5 Grifols Recent Development
12.2 CSL Behring
12.2.1 CSL Behring Company Details
12.2.2 Company Description and Business Overview
12.2.3 Guillain-Barré Syndrome Introduction
12.2.4 CSL Behring Revenue in Guillain-Barré Syndrome Business (2014-2019)
12.2.5 CSL Behring Recent Development
12.3 Octapharma
12.3.1 Octapharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Guillain-Barré Syndrome Introduction
12.3.4 Octapharma Revenue in Guillain-Barré Syndrome Business (2014-2019)
12.3.5 Octapharma Recent Development
12.4 Nihon Pharmaceutical
12.4.1 Nihon Pharmaceutical Company Details
12.4.2 Company Description and Business Overview
12.4.3 Guillain-Barré Syndrome Introduction
12.4.4 Nihon Pharmaceutical Revenue in Guillain-Barré Syndrome Business (2014-2019)
12.4.5 Nihon Pharmaceutical Recent Development
12.5 Akari Therapeutics
12.5.1 Akari Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Guillain-Barré Syndrome Introduction
12.5.4 Akari Therapeutics Revenue in Guillain-Barré Syndrome Business (2014-2019)
12.5.5 Akari Therapeutics Recent Development
12.6 China Biologic Products Holdings
12.6.1 China Biologic Products Holdings Company Details
12.6.2 Company Description and Business Overview
12.6.3 Guillain-Barré Syndrome Introduction
12.6.4 China Biologic Products Holdings Revenue in Guillain-Barré Syndrome Business (2014-2019)
12.6.5 China Biologic Products Holdings Recent Development
12.7 Biotest
12.7.1 Biotest Company Details
12.7.2 Company Description and Business Overview
12.7.3 Guillain-Barré Syndrome Introduction
12.7.4 Biotest Revenue in Guillain-Barré Syndrome Business (2014-2019)
12.7.5 Biotest Recent Development
12.8 Kedrion
12.8.1 Kedrion Company Details
12.8.2 Company Description and Business Overview
12.8.3 Guillain-Barré Syndrome Introduction
12.8.4 Kedrion Revenue in Guillain-Barré Syndrome Business (2014-2019)
12.8.5 Kedrion Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Guillain-Barré Syndrome Key Market Segments
Table Key Players Guillain-Barré Syndrome Covered
Table Global Guillain-Barré Syndrome Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Guillain-Barré Syndrome Market Size Market Share by Type 2014-2025
Figure Intravenous Immunoglobulin Figures
Table Key Players of Intravenous Immunoglobulin
Figure Plasma Exchange Figures
Table Key Players of Plasma Exchange
Figure Analgesics Figures
Table Key Players of Analgesics
Figure Anticonvulsants Figures
Table Key Players of Anticonvulsants
Figure LMWH Figures
Table Key Players of LMWH
Table Global Guillain-Barré Syndrome Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Home Care Case Studies
Figure Clinics Case Studies
Figure Guillain-Barré Syndrome Report Years Considered
Table Global Guillain-Barré Syndrome Market Size 2014-2025 (Million US$)
Figure Global Guillain-Barré Syndrome Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Guillain-Barré Syndrome Market Size by Regions 2014-2025 (Million US$)
Table Global Guillain-Barré Syndrome Market Size by Regions 2014-2019 (Million US$)
Table Global Guillain-Barré Syndrome Market Share by Regions 2014-2019
Figure Global Guillain-Barré Syndrome Market Share by Regions 2014-2019
Figure Global Guillain-Barré Syndrome Market Share by Regions 2019
Table Market Top Trends
Table Global Guillain-Barré Syndrome Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Guillain-Barré Syndrome Market Share by Manufacturers (2014-2019)
Figure Global Guillain-Barré Syndrome Market Share by Manufacturers in 2018
Table Global Guillain-Barré Syndrome Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Guillain-Barré Syndrome Product/Solution/Service
Table Date of Enter into Guillain-Barré Syndrome Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Guillain-Barré Syndrome Market Size by Type (2014-2019) (Million US$)
Table Global Guillain-Barré Syndrome Market Size Share by Type (2014-2019)
Figure Global Guillain-Barré Syndrome Market Size Market Share by Type (2014-2019)
Table Global Guillain-Barré Syndrome Market Size by Application (2014-2019) (Million US$)
Table Global Guillain-Barré Syndrome Market Size Share by Application (2014-2019)
Figure Global Guillain-Barré Syndrome Market Size Market Share by Application (2014-2019)
Figure Global Guillain-Barré Syndrome Revenue Market Share by Application in 2018
Figure United States Guillain-Barré Syndrome Market Size 2014-2019 (Million US$)
Table United States Key Players Guillain-Barré Syndrome Revenue (2018-2019) (Million US$)
Table United States Key Players Guillain-Barré Syndrome Market Share (2018-2019)
Table United States Guillain-Barré Syndrome Market Size by Type (2014-2019) (Million US$)
Table United States Guillain-Barré Syndrome Market Share by Type (2014-2019)
Table United States Guillain-Barré Syndrome Market Size by Application (2014-2019) (Million US$)
Table United States Guillain-Barré Syndrome Market Share by Application (2014-2019)
Figure Europe Guillain-Barré Syndrome Market Size 2014-2019 (Million US$)
Table Europe Key Players Guillain-Barré Syndrome Revenue (2018-2019) (Million US$)
Table Europe Key Players Guillain-Barré Syndrome Market Share (2018-2019)
Table Europe Guillain-Barré Syndrome Market Size by Type (2014-2019) (Million US$)
Table Europe Guillain-Barré Syndrome Market Share by Type (2014-2019)
Table Europe Guillain-Barré Syndrome Market Size by Application (2014-2019) (Million US$)
Table Europe Guillain-Barré Syndrome Market Share by Application (2014-2019)
Figure China Guillain-Barré Syndrome Market Size 2014-2019 (Million US$)
Table China Key Players Guillain-Barré Syndrome Revenue (2018-2019) (Million US$)
Table China Key Players Guillain-Barré Syndrome Market Share (2018-2019)
Table China Guillain-Barré Syndrome Market Size by Type (2014-20189) (Million US$)
Table China Guillain-Barré Syndrome Market Share by Type (2014-2019)
Table China Guillain-Barré Syndrome Market Size by Application (2014-2019) (Million US$)
Table China Guillain-Barré Syndrome Market Share by Application (2014-2019)
Figure Japan Guillain-Barré Syndrome Market Size 2014-2019 (Million US$)
Table Japan Key Players Guillain-Barré Syndrome Revenue (2018-2019) (Million US$)
Table Japan Key Players Guillain-Barré Syndrome Market Share (2018-2019)
Table Japan Guillain-Barré Syndrome Market Size by Type (2014-2019) (Million US$)
Table Japan Guillain-Barré Syndrome Market Share by Type (2014-2019)
Table Japan Guillain-Barré Syndrome Market Size by Application (2014-2019) (Million US$)
Table Japan Guillain-Barré Syndrome Market Share by Application (2014-2019)
Figure Southeast Asia Guillain-Barré Syndrome Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Guillain-Barré Syndrome Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Guillain-Barré Syndrome Market Share (2018-2019)
Table Southeast Asia Guillain-Barré Syndrome Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Guillain-Barré Syndrome Market Share by Type (2014-2019)
Table Southeast Asia Guillain-Barré Syndrome Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Guillain-Barré Syndrome Market Share by Application (2014-2019)
Figure India Guillain-Barré Syndrome Market Size 2014-2019 (Million US$)
Table India Key Players Guillain-Barré Syndrome Revenue (2018-2019) (Million US$)
Table India Key Players Guillain-Barré Syndrome Market Share (2018-2019)
Table India Guillain-Barré Syndrome Market Size by Type (2014-2019) (Million US$)
Table India Guillain-Barré Syndrome Market Share by Type (2014-2019)
Table India Guillain-Barré Syndrome Market Size by Application (2014-2019) (Million US$)
Table India Guillain-Barré Syndrome Market Share by Application (2014-2019)
Figure Central & South America Guillain-Barré Syndrome Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Guillain-Barré Syndrome Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Guillain-Barré Syndrome Market Share (2018-2019)
Table Central & South America Guillain-Barré Syndrome Market Size by Type (2014-2019) (Million US$)
Table Central & South America Guillain-Barré Syndrome Market Share by Type (2014-2019)
Table Central & South America Guillain-Barré Syndrome Market Size by Application (2014-2019) (Million US$)
Table Central & South America Guillain-Barré Syndrome Market Share by Application (2014-2019)
Table Grifols Company Details
Table Grifols Revenue in Guillain-Barré Syndrome Business (2014-2019) (Million US$)
Figure Grifols Revenue Growth Rate in Guillain-Barré Syndrome Business (2014-2019)
Table Grifols Recent Development
Table CSL Behring Company Details
Table CSL Behring Revenue in Guillain-Barré Syndrome Business (2014-2019)(Million US$)
Figure CSL Behring Revenue Growth Rate in Guillain-Barré Syndrome Business (2014-2019)
Table CSL Behring Recent Development
Table Octapharma Company Details
Table Octapharma Revenue in Guillain-Barré Syndrome Business (2014-2019)(Million US$)
Figure Octapharma Revenue Growth Rate in Guillain-Barré Syndrome Business (2014-2019)
Table Octapharma Recent Development
Table Nihon Pharmaceutical Company Details
Table Nihon Pharmaceutical Revenue in Guillain-Barré Syndrome Business (2014-2019)(Million US$)
Figure Nihon Pharmaceutical Revenue Growth Rate in Guillain-Barré Syndrome Business (2014-2019)
Table Nihon Pharmaceutical Recent Development
Table Akari Therapeutics Company Details
Table Akari Therapeutics Revenue in Guillain-Barré Syndrome Business (2014-2019)(Million US$)
Figure Akari Therapeutics Revenue Growth Rate in Guillain-Barré Syndrome Business (2014-2019)
Table Akari Therapeutics Recent Development
Table China Biologic Products Holdings Company Details
Table China Biologic Products Holdings Revenue in Guillain-Barré Syndrome Business (2014-2019)(Million US$)
Figure China Biologic Products Holdings Revenue Growth Rate in Guillain-Barré Syndrome Business (2014-2019)
Table China Biologic Products Holdings Recent Development
Table Biotest Company Details
Table Biotest Revenue in Guillain-Barré Syndrome Business (2014-2019)(Million US$)
Figure Biotest Revenue Growth Rate in Guillain-Barré Syndrome Business (2014-2019)
Table Biotest Recent Development
Table Kedrion Company Details
Table Kedrion Revenue in Guillain-Barré Syndrome Business (2014-2019)(Million US$)
Figure Kedrion Revenue Growth Rate in Guillain-Barré Syndrome Business (2014-2019)
Table Kedrion Recent Development
Table Global Guillain-Barré Syndrome Market Size by Regions (Million US$) 2019-2025
Figure Global Guillain-Barré Syndrome Market Size Share by Regions (2019-2025)
Figure Global Guillain-Barré Syndrome Market Size Share by Regions in 2025
Figure United States Guillain-Barré Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure Europe Guillain-Barré Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure China Guillain-Barré Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure Japan Guillain-Barré Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Guillain-Barré Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure India Guillain-Barré Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Guillain-Barré Syndrome Market Size Forecast (2019-2025)(Million USD)
Table Global Guillain-Barré Syndrome Market Size by Product (2019-2025) (Million US$)
Figure Global Guillain-Barré Syndrome Market Size by Product (2019-2025)
Figure Global Guillain-Barré Syndrome Market Size by Product in 2025
Table Global Guillain-Barré Syndrome Market Size by Application (2019-2025) (Million US$)
Figure Global Guillain-Barré Syndrome Market Size by Application (2019-2025)
Figure Global Guillain-Barré Syndrome Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
クッシング症候群および末端肥大症の治療の世界市場：市場規模・現状・予測 Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. Acromegaly …- 短腸症候群（SBS）の世界市場：市場規模・現状・予測 Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…
- 短腸症候群（SBS）治療薬の世界市場：市場規模・現状・予測 Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…
- ランバート-イートン筋無力症候群治療の世界市場：市場規模・現状・予測 Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder involving nerves and muscles that results in significant muscle weakness. It is often associated with certain types of cancer or other autoimmune disorders. It is caused by faulty nerve cells that fail to release sufficient amounts o…
- 吸収不良症候群の世界市場：市場規模・現状・予測 Malabsorption syndrome refers to a number of disorders in which the small intestine can’t absorb enough of certain nutrients and fluids. These nutrients can be macronutrients (proteins, carbohydrates, and fats), micronutrients (vitamins and minerals), or both.Treatment of Malabsorption is directed l…